CatSci Ltd are pleased to announce that we will be attending CPHI North America 2023.
Attending CPHI North America will be:
- Dr Jas Douville, our Head of Business Development – US
- Dr Jenny Wallis, our Head of Business Development – New England
Taking place on 25th – 27th April 2023, CPHI North America will be held in Pennsylvania Convention Center, Philadelphia. CPHI North America is one of the premier events connecting the entire US pharmaceutical drug development and manufacturing supply chain.
Jas and Jenny are looking forward to discussing your portfolio challenges and how CatSci’s scalable small molecule API development and manufacturing in collaboration with AGC Pharma Chemicals Europe, from grams to tonnes, can help you expedite your path to clinic.
Our partnership enables CatSci to support programs from pre-clinical development, through to large scale commercial production of GMP material with full control and accountability of the tech transfer process.
We are also looking forward to discussing your oligonucleotides programmes and how our new oligonucleotides capability allows us to synthesise, purify, analyse and fully optimise the synthetic and downstream processes of your oligonucleotides efficiently and effectively.
We can synthesis all classes of therapeutic oligonucleotides, including siRNA, ASO, Gapmers, and sgRNA, as well as GalNAc Ligands and other conjugates.
If you want to arrange a meeting with Jas and Jenny at CPHI North America, get in touch here.
